---
figid: PMC9113869__OMCL2022-6839385.007
pmcid: PMC9113869
image_filename: OMCL2022-6839385.007.jpg
figure_link: /pmc/articles/PMC9113869/figure/fig7/
number: Figure 7
figure_title: ''
caption: 'AKG promoted the activity and expression of c-Fos, which increased OGD/R-induced
  IL-10 expression. (a) An AP-1 transcription factor assay kit was used to evaluate
  AP-1 activity (n = 5). (b) Jund, Junb, c-Jun, Fos-b, c-Fos, Fosl2, and Fosl1 mRNA
  levels in different treatments by using RT-qPCR (n = 4). (c) Representative blots
  and quantitative analysis of IL-10 and stat3 (n = 4). (d–i) Representative blots
  and quantitative analysis of P-c-Fos, T-c-Fos, IL-1, IL-6, and IL-10 (n = 4 per
  group). (a and b) ∗P < 0.05 versus the OGD/R group. (e and g) ∗∗P < 0.01 versus
  the OGD/R group. (i) ∗∗P < 0.01 versus the OGD/R group and #P < 0.05 and ##P < 0.01
  versus the OGD/R+AKG50 group.'
article_title: AKG Attenuates Cerebral Ischemia-Reperfusion Injury through c-Fos/IL-10/Stat3
  Signaling Pathway.
citation: Weilong Hua, et al. Oxid Med Cell Longev. 2022;2022:6839385.
year: '2022'

doi: 10.1155/2022/6839385
journal_title: Oxidative Medicine and Cellular Longevity
journal_nlm_ta: Oxid Med Cell Longev
publisher_name: Hindawi

keywords:
---
